NCI-H2029Homo sapiens (Human)Cancer cell line

Also known as: NCIH2029, H-2029, H2029

🤖 AI SummaryBased on 7 publications

Quick Overview

Human lung cancer cell line with known RB mutations and potential for drug sensitivity studies.

Detailed Summary

The NCI-H2029 cell line is a human lung cancer cell line derived from a patient with small cell lung cancer. It is characterized by mutations in the RB gene, which is a key tumor suppressor gene involved in cell cycle regulation. This cell line has been used in studies examining the role of RB-related genes and SV40 large T antigen in cancer development. Research has shown that NCI-H2029 exhibits specific patterns of protein expression and genetic alterations that may influence its response to anticancer drugs. The cell line is part of the Cancer Cell Line Encyclopedia (CCLE) and has been utilized in predictive modeling of drug sensitivity. Its genetic profile makes it a valuable resource for studying the molecular mechanisms of lung cancer and developing targeted therapies.

Research Applications

RB gene mutation analysisDrug sensitivity profilingCancer cell line encyclopedia (CCLE)SV40 large T antigen studies

Key Characteristics

RB gene mutationsSmall cell lung cancer originPart of CCLE databasePotential for drug response studies
Generated on 6/17/2025

Basic Information

Database IDCVCL_1516
SpeciesHomo sapiens (Human)
Tissue SourceLymph node[UBERON:UBERON_0000029]

Donor Information

Age69
Age CategoryAdult
SexFemale
Racecaucasian

Disease Information

DiseaseSmall cell lung cancer
LineageLung
SubtypeSmall Cell Lung Cancer
OncoTree CodeSCLC

DepMap Information

Source TypeATCC
Source IDACH-000298_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Tyr220Asp (c.658T>G)Unspecified-PubMed=27693639
MutationSimpleRB1c.265-1G>THomozygousSplice acceptor mutationUnknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,11
D13S317
11,14
D16S539
12
D18S51
15
D19S433
14,15
D21S11
30,31.2
D2S1338
17,22
D3S1358
16,17
D5S818
10,11
D7S820
9,11
D8S1179
11,15
FGA
21,25
Penta D
9
Penta E
9
TH01
7,9.3
TPOX
8
vWA
15,19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

From clinical specimens to human cancer preclinical models -- a journey the NCI-cell line database-25 years later.

Aldige C.R., Wistuba I.I., Minna J.D.

J. Cell. Biochem. 121:3986-3999(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Lung cancer cell lines as tools for biomedical discovery and research.

Gazdar A.F., Girard L., Lockwood W.W., Lam W.L., Minna J.D.

J. Natl. Cancer Inst. 102:1310-1321(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.

Modi S., Kubo A., Oie H.K., Coxon A.B., Rehmatulla A., Kaye F.J.

Oncogene 19:4632-4639(2000).

MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer.

Ihde D.C., Gazdar A.F.

J. Cell. Biochem. Suppl. 24:210-217(1996).

NCI-Navy Medical Oncology Branch cell line data base.";

Carney D.N., Minna J.D., Mulshine J.L.

J. Cell. Biochem. Suppl. 24:32-91(1996).